Anthrax vaccine - Emergent BioSolutionsAlternative Names: Oral anthrax vaccine - Emergent BioSolutions
Latest Information Update: 14 Aug 2009
At a glance
- Originator Emergent BioSolutions
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Anthrax
Most Recent Events
- 04 Sep 2006 No development reported - Preclinical for Anthrax in United Kingdom (PO)
- 27 Jun 2005 Microscience has been acquired by Emergent BioSolutions
- 05 Aug 2003 Preclinical trials in Anthrax in United Kingdom (PO)